Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_assertion type Assertion NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_head.
- NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_assertion wasGeneratedBy ECO_0000203 NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_provenance.
- NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_assertion wasDerivedFrom befree-20150227 NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_provenance.
- NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_assertion SIO_000772 19301661 NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_provenance.
- NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_assertion evidence source_evidence_literature NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_provenance.
- NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_assertion description "[Here we show that in vivo application of targeted nonvirally delivered synthetic bcr-abl siRNA in a female patient with recurrent Philadelphia chromosome positive chronic myeloid leukemia (CML) resistant to imatinib (Y253F mutation) and chemotherapy after allogeneic hematopoietic stem cell transplantation can silence the expression of bcr-abl gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219401.RAd09NGBahbFIv-70eutGp0XW2esK6lJtHcnPS-hQcC1k130_provenance.